Drug Oncology

Mozobil

Payments companies reported to CMS as associated with Mozobil. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$6,210associated payments (2023-2025)
77clinicians with associated payments
1company reporting

By year

2023 $4,470
2024 $1,398
2025 $342

Payments reported as associated with Mozobil, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Nurse Practitioner $1,040
Adult Health (Nurse Practitioner) $757
Family $753
Hematology & Oncology $730
Physician Assistant $695
Medical $254

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Mozobil

These are the largest totals companies reported as associated with Mozobil. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Laura Besaw Orlando, FL Nurse Practitioner $176.99
Elizabeth Schonhoft Boston, MA Family $174.00
Melissa Hovak Buffalo, NY Nurse Practitioner $99.99
Gladiz Martinez Aurora, CO Medical-Surgical (Clinical Nurse Specialist) $99.99
Shakuntala Shrestha Pembroke Pines, FL Nurse Practitioner $99.99
Dominic Sanchez-Paredes San Juan, PR $99.99
Deepthi Krishna Buffalo, NY Physician Assistant $99.99
Parveen Minhas Buffalo, NY Adult Health (Nurse Practitioner) $99.99
Diem Chu Houston, TX Physician Assistant $99.99
Laura Acker Houston, TX Physician Assistant $99.99

Prescribed Mozobil?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.